Literature DB >> 24662652

Diagnostic utility of (18)F-FDG PET/CT in inflammation of unknown origin.

Hans Balink1, Roel J Bennink, Nic J G M Veeger, Berthe L F van Eck-Smit, Hein J Verberne.   

Abstract

OBJECTIVES: The goal of this multicenter retrospective study was to evaluate the contribution of F-FDG PET/CT in the diagnosis of patients with inflammation of unknown origin (IUO). In addition, C-reactive protein (CRP) level and erythrocyte sedimentation rate were assessed as possible predictors for the outcome of F-FDG PET/CT.
METHODS: Inflammation of unknown origin was defined as prolonged and perplexing inflammation, with repeated CRP levels more than 20 mg/L or erythrocyte sedimentation rate more than 20 mm/h, body temperature of less than 38.3°C, and without a diagnosis after a variety of conventional diagnostic procedures.A total of 140 patients with IUO (67 men, 73 women; mean age, 64.2 years; age range, 18-87 years) underwent F-FDG PET/CT. F-FDG PET/CT was considered helpful when the imaging findings led to a diagnosis, either confirmed by histopathology, microbiological assays, clinical and imaging follow-up, or response to treatment.
RESULTS: In 104 patients (73%), a final diagnosis could be established as follows: infection in 35 patients, malignancy in 18 patients, noninfectious inflammatory disease in 44 patients, and a variety of uncommon conditions in 7 patients. F-FDG PET/CT was true positive in 95 patients, true negative in 30 patients (ie, self-limiting conditions), false positive in 6 patients, and false negative in 9 patients (predominantly systemic diseases). In this population, the positive predictive value, negative predictive value, and diagnostic accuracy of F-FDG PET/CT were 94%, 77%, and 89%, respectively. In a multivariate analysis, CRP was the only independent predictor for the outcome of F-FDG PET/CT.
CONCLUSIONS: F-FDG PET/CT correctly identified or excluded a causal explanation in approximately 90% of patients with IUO. However, a negative F-FDG PET/CT is indicative for a self-limiting condition only after systemic diseases are excluded by other diagnostic tests.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662652     DOI: 10.1097/RLU.0000000000000423

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  7 in total

1.  18F-FDGPET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study.

Authors:  Qian Wang; Ya-Ming Li; Yuan Li; Feng-Chun Hua; Quan-Shi Wang; Xiao-Li Zhang; Chao Cheng; Hua Wu; Zhi-Ming Yao; Wei-Fang Zhang; Qing-Yi Hou; Wei-Bing Miao; Xue-Mei Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-11       Impact factor: 9.236

2.  ¹⁸F-FDG PET/CT in inflammation of unknown origin: a cost-effectiveness pilot-study.

Authors:  H Balink; S S Tan; N J G M Veeger; F Holleman; B L F van Eck-Smit; R J Bennink; H J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-06       Impact factor: 9.236

Review 3.  Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2022-07-04       Impact factor: 2.374

Review 4.  The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria?

Authors:  H Balink; R J Bennink; B L F van Eck-Smit; H J Verberne
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

5.  The efficacy of steroids for postoperative persistent inflammatory reaction in a patient with barium peritonitis: A case report.

Authors:  Hirofumi Kojima; Shozo Hojo; Takahiro Manabe; Shiori Demura; Shinichi Sekine; Kazuto Shibuya; Isaya Hashimoto; Isaku Yoshioka; Tomoyuki Okumura; Takuya Nagata; Tsutomu Fujii
Journal:  Int J Surg Case Rep       Date:  2017-05-15

6.  Inflammation of Unknown Origin: Evaluation and Prognosis of 57 Cases.

Authors:  Suzanne Béra; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Stéphane Durupt; Raphaèle Nove-Josserand; Jean-Christophe Lega; Isabelle Durieu; Arnaud Hot; Pascal Sève
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

7.  Role of 18F-fluorodeoxyglucose (FDG) and 18F-2-fluorodeoxy sorbitol (FDS) in autoimmune hypophysitis: a case report.

Authors:  Ziren Kong; Yu Wang; Wenbin Ma; Xin Cheng
Journal:  BMC Endocr Disord       Date:  2020-06-09       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.